Lucas Ward
Stock Analyst at Ascendiant Capital
(0.22)
# 4,172
Out of 4,873 analysts
17
Total ratings
17.65%
Success rate
-42.37%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LIQT LiqTech International | Maintains: Buy | $3.4 → $3.6 | $1.49 | +142.42% | 5 | Jun 16, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Maintains: Buy | $5.8 → $7 | $2.33 | +201.08% | 2 | Jun 2, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $6.6 → $6.2 | $2.92 | +112.33% | 3 | Apr 15, 2025 | |
| HSCS HeartSciences | Maintains: Buy | $15 → $14 | $3.71 | +277.87% | 2 | Mar 18, 2025 | |
| ACON Aclarion | Maintains: Buy | $555 → $481 | $6.82 | +6,952.79% | 3 | Nov 27, 2024 | |
| VMAR Vision Marine Technologies | Maintains: Buy | $3,375 → $2,700 | $7.40 | +36,411.16% | 2 | Jul 29, 2024 |
LiqTech International
Jun 16, 2025
Maintains: Buy
Price Target: $3.4 → $3.6
Current: $1.49
Upside: +142.42%
60 Degrees Pharmaceuticals
Jun 2, 2025
Maintains: Buy
Price Target: $5.8 → $7
Current: $2.33
Upside: +201.08%
Vivos Therapeutics
Apr 15, 2025
Maintains: Buy
Price Target: $6.6 → $6.2
Current: $2.92
Upside: +112.33%
HeartSciences
Mar 18, 2025
Maintains: Buy
Price Target: $15 → $14
Current: $3.71
Upside: +277.87%
Aclarion
Nov 27, 2024
Maintains: Buy
Price Target: $555 → $481
Current: $6.82
Upside: +6,952.79%
Vision Marine Technologies
Jul 29, 2024
Maintains: Buy
Price Target: $3,375 → $2,700
Current: $7.40
Upside: +36,411.16%